Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome

NCT07476859 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

538

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndromes (ACS)
Iron Deficiencies
Elderly (People Aged 65 or More)

Interventions

DRUG: Ferric Carboxymaltose Injection [Ferinject]

Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia

Collaborators

[object Object]